Liaoning Haisco Pharmaceutical describes new crystalline salts of CYP11A1 inhibitors
Dec. 18, 2025
Liaoning Haisco Pharmaceutical Co. Ltd. has identified crystalline salts of known cholesterol side-chain cleavage enzyme, mitochondrial (CYP11A1) inhibitors reported to be useful for the treatment of cancer.